Literature DB >> 30304372

Mitochondrial biology and prostate cancer ethnic disparity.

Jialin Xiao1, Pinchas Cohen1, Mariana Carla Stern2, Folakemi Odedina3, John Carpten4, Renee Reams5.   

Abstract

Prostate cancer remains the second most prevalent cancer in men. Its incidence, progression and mortality profiles vary significantly by race and ethnicity, with African-American men having the highest incidence rate and mortality rate in the world. Although these disparities can be partially explained by socioeconomic factors, the underlying molecular causes are complex and require careful research. A considerable amount of literature exists, supporting the association between mitochondrial health and the incidence, aggression and risk of prostate cancer. Genetic alterations in mitochondrial DNA are frequent in prostate cancer; therefore, the resulting mitochondrial dysfunction and metabolic dysregulation may contribute to or indicate oncogenesis. Many of the prominent features of cancer cells are also closely related to mitochondrial functions, such as resistance to apoptosis, excess reactive oxygen species production and altered oxidative phosphorylation. In addition, prostate cancer ethnic disparity is influenced by environmental and lifestyle factors, which involves differences in mitochondrial metabolism and retrograde signaling events.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30304372      PMCID: PMC6292412          DOI: 10.1093/carcin/bgy133

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  77 in total

Review 1.  Crosstalk between nuclear and mitochondrial genomes.

Authors:  R O Poyton; J E McEwen
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

2.  North American white mitochondrial haplogroups in prostate and renal cancer.

Authors:  Lyra M Booker; Geoffrey M Habermacher; Benjamin C Jessie; Qi Carrie Sun; Amanda K Baumann; Mahul Amin; So Dug Lim; Carina Fernandez-Golarz; Robert H Lyles; Michael D Brown; Fray F Marshall; John A Petros
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

3.  mtDNA mutations increase tumorigenicity in prostate cancer.

Authors:  John A Petros; Amanda K Baumann; Eduardo Ruiz-Pesini; Mahul B Amin; Carrie Qi Sun; John Hall; SoDug Lim; Muta M Issa; W Dana Flanders; Seyed H Hosseini; Fray F Marshall; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

4.  Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis.

Authors:  Tung H Ngo; R James Barnard; Pinchas Cohen; Stephen Freedland; Chris Tran; Frank deGregorio; Yahya I Elshimali; David Heber; William J Aronson
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

5.  Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.

Authors:  W H Lee; R A Morton; J I Epstein; J D Brooks; P A Campbell; G S Bova; W S Hsieh; W B Isaacs; W G Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

6.  Prostate cancer in African American men is associated with downregulation of zinc transporters.

Authors:  Irum Rishi; Hasna Baidouri; Jamil A Abbasi; Rebecca Bullard-Dillard; Andre' Kajdacsy-Balla; Joseph P Pestaner; Marek Skacel; Raymond Tubbs; Omar Bagasra
Journal:  Appl Immunohistochem Mol Morphol       Date:  2003-09

7.  The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice.

Authors:  Phuong T Hoang; Patricia Park; Laura J Cobb; Valdislava Paharkova-Vatchkova; Michael Hakimi; Pinchas Cohen; Kuk-Wha Lee
Journal:  Metabolism       Date:  2009-10-01       Impact factor: 8.694

8.  Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer.

Authors:  Anton M F Kalsbeek; Eva F K Chan; Judith Grogan; Desiree C Petersen; Weerachai Jaratlerdsiri; Ruta Gupta; Ruth J Lyons; Anne-Maree Haynes; Lisa G Horvath; James G Kench; Phillip D Stricker; Vanessa M Hayes
Journal:  Aging (Albany NY)       Date:  2016-10-05       Impact factor: 5.682

9.  Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy.

Authors:  Keri L Schadler; Nicholas J Thomas; Peter A Galie; Dong Ha Bhang; Kerry C Roby; Prince Addai; Jacob E Till; Kathleen Sturgeon; Alexander Zaslavsky; Christopher S Chen; Sandra Ryeom
Journal:  Oncotarget       Date:  2016-10-04

10.  Universal heteroplasmy of human mitochondrial DNA.

Authors:  Brendan A I Payne; Ian J Wilson; Patrick Yu-Wai-Man; Jonathan Coxhead; David Deehan; Rita Horvath; Robert W Taylor; David C Samuels; Mauro Santibanez-Koref; Patrick F Chinnery
Journal:  Hum Mol Genet       Date:  2012-10-16       Impact factor: 6.150

View more
  13 in total

1.  ERR1 and PGC1α associated mitochondrial alterations correlate with pan-cancer disparity in African Americans.

Authors:  Danthasinghe Waduge Badrajee Piyarathna; Akhila Balasubramanian; James M Arnold; Stacy M Lloyd; Balasubramanyam Karanam; Patricia Castro; Michael M Ittmann; Nagireddy Putluri; Nora Navone; Jeffrey A Jones; Wendong Yu; Vlad C Sandulache; Andrew G Sikora; George Michailidis; Arun Sreekumar
Journal:  J Clin Invest       Date:  2019-03-28       Impact factor: 14.808

Review 2.  Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting.

Authors:  Andrea K Miyahira; Jelani C Zarif; Catherine C Coombs; Robert R Flavell; Joshua W Russo; Samir Zaidi; Di Zhao; Shuang G Zhao; Kenneth J Pienta; Howard R Soule
Journal:  Prostate       Date:  2021-11-03       Impact factor: 4.104

Review 3.  Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations.

Authors:  Rebecca Morgan; Willian Abraham da Silveira; Ryan Christopher Kelly; Ian Overton; Emma H Allott; Gary Hardiman
Journal:  Expert Rev Mol Diagn       Date:  2021-11-25       Impact factor: 5.225

Review 4.  Targeting mitochondrial metabolism for metastatic cancer therapy.

Authors:  Antonino Passaniti; Myoung Sook Kim; Brian M Polster; Paul Shapiro
Journal:  Mol Carcinog       Date:  2022-06-20       Impact factor: 5.139

5.  Community and Research Perspectives on Cancer Disparities in Wisconsin.

Authors:  Jessica Olson; Tobi Cawthra; Kirsten Beyer; David Frazer; Lyle Ignace; Cheryl Maurana; Sandra Millon-Underwood; Laura Pinsoneault; Jose Salazar; Alonzo Walker; Carol Williams; Melinda Stolley
Journal:  Prev Chronic Dis       Date:  2020-10-08       Impact factor: 2.830

Review 6.  Why do African-American men face higher risks for lethal prostate cancer?

Authors:  Sujit S Nair; Dimple Chakravarty; Zachary S Dovey; Xiangfu Zhang; Ashutosh K Tewari
Journal:  Curr Opin Urol       Date:  2022-01-01       Impact factor: 2.309

7.  PPFIA4 promotes castration-resistant prostate cancer by enhancing mitochondrial metabolism through MTHFD2.

Authors:  Ru Zhao; Tingting Feng; Lin Gao; Feifei Sun; Qianqian Zhou; Xin Wang; Junmei Liu; Wenbo Zhang; Meng Wang; Xueting Xiong; Wenqiao Jia; Weiwen Chen; Lin Wang; Bo Han
Journal:  J Exp Clin Cancer Res       Date:  2022-04-05

Review 8.  Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.

Authors:  Olga Golubnitschaja; Peter Kubatka; Alena Mazurakova; Marek Samec; Abdullah Alajati; Frank A Giordano; Vincenzo Costigliola; Jörg Ellinger; Manuel Ritter
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

Review 9.  Mitochondrial DNA variation and cancer.

Authors:  Piotr K Kopinski; Larry N Singh; Shiping Zhang; Marie T Lott; Douglas C Wallace
Journal:  Nat Rev Cancer       Date:  2021-05-27       Impact factor: 60.716

Review 10.  Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.

Authors:  Zachary S Dovey; Sujit S Nair; Dimple Chakravarty; Ashutosh K Tewari
Journal:  Cancer Rep (Hoboken)       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.